Chromatin Inc:企業のM&A・事業提携・投資動向

◆英語タイトル:Chromatin Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C2012
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:62
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Chromatin Inc – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Chromatin Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Chromatin Inc since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Chromatin Inc’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Chromatin Inc. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Chromatin Inc’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Chromatin Inc and its subsidiaries since 2007.
- Information about key financial and legal advisors for Chromatin Inc’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Chromatin Inc’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 6
LIST OF FIGURES 6
TARGETS AND PARTNERS 7
MERGERS & ACQUISITIONS 8
Mergers and Acquisitions – Overview 8
Mergers and Acquisitions – Deal reports 9
PARTNERSHIP 17
Partnership – Overview 17
Partnership – Deal reports 18
CAPITAL RAISING 39
Capital Raising – Overview 39
Capital Raising – Deal reports 40
APPENDIX 52
Contact Us 52
About MarketLine Financial Deals Database 52
Deal Definition and Methodology 54
About MarketLine 61

List of Tables
Table 1: Chromatin Inc M&A volume and value trend (2014-YTD2018)
Table 2: Chromatin Inc M&A activity by geography (2014-YTD2018)
Table 3: Chromatin Inc partnership volume and value trend (2014-YTD2018)
Table 4: Chromatin Inc partnership trend by key deal type (2014-YTD2018)
Table 5: Chromatin Inc capital raising volume and value trend (2014-YTD2018)
Table 6: Chromatin Inc capital raising by deal type (2014-YTD2018)

List of Figures
Figure 1: Chromatin Inc M&A volume and value trend (2014-YTD2018)
Figure 2: Chromatin Inc M&A activity by geography (2014-YTD2018)
Figure 3: Chromatin Inc partnership volume and value trend (2014-YTD2018)
Figure 4: Chromatin Inc partnership trend by key deal type (2014-YTD2018)
Figure 5: Chromatin Inc capital raising volume and value trend (2014-YTD2018)
Figure 6: Chromatin Inc capital raising by deal type (2014-YTD2018)

★海外企業調査レポート[Chromatin Inc:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Jubilee Life Insurance Company Limited:企業の戦略・SWOT・財務情報
    Jubilee Life Insurance Company Limited - Strategy, SWOT and Corporate Finance Report Summary Jubilee Life Insurance Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • ASML Holding N.V.:企業の戦略・SWOT・財務情報
    ASML Holding N.V. - Strategy, SWOT and Corporate Finance Report Summary ASML Holding N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Fresenius SE & Co KGaA (FRE)-製薬・医療分野:企業M&A・提携分析
    Summary Fresenius SE & Co KGaA (Fresenius) is a global health care group, which offers products and services for dialysis treatment. It provides various dialysis services through its own clinics and sells its products to other dialysis service providers. Its major products and services includes mach …
  • Cloud Cap Technology Inc.:企業の戦略・SWOT・財務情報
    Cloud Cap Technology Inc. - Strategy, SWOT and Corporate Finance Report Summary Cloud Cap Technology Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Comision Federal de Electricidad:企業の戦略的SWOT分析
    Comision Federal de Electricidad - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • China Yurun Food Group Limited:企業の戦略・SWOT・財務情報
    China Yurun Food Group Limited - Strategy, SWOT and Corporate Finance Report Summary China Yurun Food Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • AnaMar AB-医療機器分野:企業M&A・提携分析
    Summary AnaMar AB (AnaMar), a subsidiary of Koncentra Holding AB, discovers, develops and commercializes therapeutic strategies to treat debilitating inflammation, fibrosis and pain. The company develops drug candidates from several chemical classes that concentrates on the receptors and shows poten …
  • Punjab National Bank (PNB):企業の財務・戦略的SWOT分析
    Punjab National Bank (PNB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Mednax Inc (MD)-製薬・医療分野:企業M&A・提携分析
    Summary Mednax Inc (Mednax) is a national medical group company, which operates a network of physician service providers. The company offers a wide range of neonatal, anesthesia, maternal-fetal, pediatric physician and subspecialty services. Its network includes other pediatric subspecialists compri …
  • Rad Source Technologies Inc:企業の戦略的SWOT分析
    Rad Source Technologies Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Pharmicell Co Ltd (005690):製薬・医療:M&Aディール及び事業提携情報
    Summary Pharmicell Co Ltd (Pharmicell), formerly Yuhaw Trade Co Ltd is a biopharmaceutical company that discovers, develops, and commercializes stem cell drugs. The company offers pipeline products such as Cellgram_AMI a heart disease drug, Cellgram_Lung a pulmonary disease drug, and Cellgram_IS and …
  • Barbara Ann Karmanos Cancer Institute-製薬・医療分野:企業M&A・提携分析
    Summary Barbara Ann Karmanos Cancer Institute (Karmanos), a subsidiary of McLaren Health Care Corp is a healthcare institute that provides patient care and educational services. The institute offers patient care for the prevention, early detection, treatment and eventual eradication of cancer. Its c …
  • Ocular Therapeutix Inc (OCUL):企業の財務・戦略的SWOT分析
    Summary Ocular Therapeutix Inc (Ocular Therapeutix), formerly I-Therapeutix Inc, is a biopharmaceutical company that discovers, develops and commercializes therapies for treating eye diseases. The company’s lead product candidate DEXTENZA is used for the treatment of post-surgical ocular inflammatio …
  • Imuraya Group Co., Ltd.:企業の戦略・SWOT・財務分析
    Imuraya Group Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Imuraya Group Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Cosmo Energy Holdings Co Ltd (5021):企業の財務・戦略的SWOT分析
    Cosmo Energy Holdings Co Ltd (5021) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • DCP Midstream, LP:企業の戦略・SWOT・財務分析
    DCP Midstream, LP - Strategy, SWOT and Corporate Finance Report Summary DCP Midstream, LP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • PhaseBio Pharmaceuticals Inc:企業のM&A・事業提携・投資動向
    PhaseBio Pharmaceuticals Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's PhaseBio Pharmaceuticals Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • Merus NV (MRUS):企業の財務・戦略的SWOT分析
    Summary Merus NV (Merus) is a clinical-stage immuno-oncology company that discovers and develops human bispecific antibody therapeutics for the treatment of cancer. The company’s pipeline antibody candidates are intended for the treatment of breast cancer, ovarian cancer, colorectal cancer, acute my …
  • Fuller, Smith & Turner Plc:企業の戦略・SWOT・財務情報
    Fuller, Smith & Turner Plc - Strategy, SWOT and Corporate Finance Report Summary Fuller, Smith & Turner Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Cheniere Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Cheniere Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Cheniere Energy Inc (Cheniere) is a midstream energy company that owns and operates LNG-related businesses. The company through its general partner, Cheniere Energy Partners, L.P. (Cheniere Partners) …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆